Solta Medical Fraxel 1550, Руководство оператора

Страница: 67 / 92

Fraxel
®
1550, Fraxel 1927 and Fraxel DUAL 1550/1927 Laser System
Part Number 10-05170 Rev. O Page 67 of 92
4.0 Physician Information
Warning:
The information which follows below is provided by Solta only as an information service to
physicians and is made available with the understanding that it does not constitute the
rendering of medical advice. Physicians should make their own assessment of and decision
on the use of any of the information.
4.1 Indications for Use
Refer to Section 1.1.
4.2 Considerations
MEDICAL JUDGEMENT SHOULD BE USED WHEN TREATING PATIENTS
WITH ANY OF THE FOLLOWING CONDITIONS:
4.2.1 Predisposition to post inflammatory hyperpigmentation (PIH)
4.2.1.1 Prophylactic bleaching regimen for skin types IV to VI for
4-6 weeks prior to first treatment, throughout treatment
regimen, and 4-6 weeks post final treatment
recommended
4.2.2 Lesion suspicious for malignancy
4.2.3 Active infection: bacterial, viral, fungal
4.2.4 Active tanning, UV exposure
4.2.5 Medication that can affect coagulation and predispose patient to
petechiae
4.2.6 Compromised ability to heal
4.2.7 Topical retinoids or retinols
4.2.8 History of cold sores
4.2.8.1 Prophylactic acyclovir regimen recommended
4.2.9 No studies on cosmetic tattoos, pregnant or nursing women, or
silicone implants